SCHEMBL7947516

SCHEMBL7947516

O=C(O)c1ccc(N2CCN(c3ccncc3)CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
USP2 O75604 1/20 0.57
NAPRT Q6XQN6 1/20 0.57
CHEK1 O14757 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
AKR1C3 P42330 1/20 0.55
CHKA P35790 1/20 0.53
CYP3A4 P08684 1/20 0.51
ALDH1A1 P00352 2/20 0.51
GAA P10253 1/20 0.51
ITGB3 P05106 1/20 0.49
ITGA2B P08514 1/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
ADRB2 P07550 1/20 0.48
NCF1 P14598 1/20 0.48
PLD1 Q13393 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
CYP2C9 P11712 2/20 0.48
MAPT P10636 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23610369 0.88 KDM4E (0.71) KDM4EUSP2CHEK1SMN1; SMN2ALDH1A1
SCHEMBL17737082 0.88 KDM4E (0.71) KDM4EUSP2CHEK1SMN1; SMN2ALDH1A1
SCHEMBL4579770 0.85 POLB (0.61) KDM4ESMN1; SMN2CYP3A4ALDH1A1ITGB3
SCHEMBL5632521 0.85 POLB (0.54) KDM4ESMN1; SMN2ALDH1A1ITGB3ITGA2B
SCHEMBL7961639 0.84 SMN1; SMN2 (0.70) KDM4EUSP2SMN1; SMN2AKR1C3CYP3A4
SCHEMBL4033968 0.84 CHEK1 (0.56) CHEK1SMN1; SMN2AKR1C3CHKACYP3A4
SCHEMBL7956272 0.84 NPC1 (0.69) SMN1; SMN2AKR1C3CHKACYP3A4ALDH1A1
SCHEMBL7404283 0.83 POLB (0.55) KDM4ESMN1; SMN2ALDH1A1HRH3MAPT
SCHEMBL7400408 0.82 KMT2A (0.58) KDM4ECHEK1SMN1; SMN2CYP3A4ALDH1A1
SCHEMBL20193318 0.82 KDM4E (0.65) KDM4EUSP2CHEK1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed